The WHO’s support for legal CBD oil puts the global community at odds with some elements in the U.S. government that continue to fight against the legalization of hemp and cannabis 2017 was an exciting year for supporters of hemp. The stigma surrounding this plant has continued to decrease as more and more people discover…
Sebastien Cotte has seen how medical marijuana eased the suffering of his son, who has an incurable neurological disorder.
What comes to mind when you think of cannabis: stoned old hippies? Teenagers smoking illicit joints? It’s about as far away from luxe skincare as you can get.
Dutch Passion are pleased to announce some new varieties for 2018. There are three THC rich varieties, Lemon Zkittle®, Auto Orange Bud and the photoperiod feminized Bubba Island Kush. And perhaps surprisingly to some, there is a new THC-free and CBD-rich variety called Charlottes Angel.
when state law and federal laws do not match it places the users in a real catch 22
A key problem in caring for patients with psychosis is that they are often reluctant to take antipsychotic drugs because of concerns about side effects – but cannabis-based treatments could change this
World Health Organisation report revealed that CBD oils may help successfully treat symptoms relating to Alzheimer’s Disease, Parkinson’s Disease, MS, pain, anxiety, depression, cancer and diabetic complications
Despite its controversial nature, the use of medical marijuana and cannabis-derived medicinal products grows more popular with each passing year. As of November 2016, over 40 states have passed legislation regarding the use of either medical marijuana or cannabidiol products. This review will deliver the history of marijuana use and legislation in the United States in addition to the currently available medical literature to equip pediatric health care providers with resources to provide patients and their parents the best recommendation for safe and appropriate use of cannabis-containing compounds.
Medical marijuana continues to gain acceptance and become legalized in many states. Various species of the marijuana plant have been cultivated, and this plant can contain up to 100 active compounds known as cannabinoids. Two cannabinoids seem the most clinically relevant: Δ9-tetrahydrocannabinol (THC), which tends to produce the psychotropic effects commonly associated with marijuana, and cannabidiol (CBD), which may produce therapeutic effects without appreciable psychoactive properties. Although there is still a need for randomized controlled trials, preliminary studies have suggested that medical marijuana and related cannabinoids may be beneficial in treating people with chronic pain, inflammation, spasticity and other conditions.
Gaps in our understanding of how economically important compounds such as cannabinoids are produced are being identified using next-generation ‘omics’ to rapidly advance biochemical breakthroughs at an unprecedented rate
Recently, cannabis has been suggested as a potential alternative therapy for refractory epilepsy, which affects 30% of epilepsy, both adults and children, who do not respond to current medications. There is a large unmet medical need for new antiepileptics that would not interfere with normal function in patients with refractory epilepsy and conditions associated with refractory seizures. The two chief cannabinoids are Δ-9-tetrahyrdrocannabinol, the major psychoactive component of marijuana, and cannabidiol (CBD), the major nonpsychoactive component of marijuana.